Today, JPMorganChase (JPMC) and Yodlee further strengthened their 20-year partnership through an amendment to their existing Data Access agreement, which includes mutual commitments and a pricing ...

"This dataset was simply too important to stop being updated." For decades, the National Oceanic and Atmospheric Administration's billion-dollar disaster dataset put a dollar figure on the cost of ...

The federal government is still shut down. And that means no federal economic data (still). But we do have a new set of economic indicators, courtesy of the private sector. The investment firm Carlyle ...

LinkedIn has filed a lawsuit against Delaware company ProAPIs Inc. and its founder and CTO, Rehmat Alam, for allegedly scraping legitimate data through more than a million fake accounts. ProAPIs ...

Social media giant LinkedIn on Thursday filed a lawsuit against a company which it says operates a network of millions of fake accounts used to scrape data from LinkedIn members before selling the ...

Zurich, 17 September 2025 – UiPath, an international provider of agentic automation, is launching the Automation Cloud™ integrated into Microsoft Azure in Switzerland with immediate effect. UiPath is ...

Valneva has reported phase 2 data on the third booster dose of its Pfizer-partnered Lyme disease vaccine candidate, ticking off another task for a prospect that could reach regulatory review next year ...

Two games concluded the 21st round of the Brasileirão 2025, this Monday (25). In the first match of the evening, Palmeiras defeated Sport 3-0, on the day of the debut of the "National Team uniform".

I am trying to extract data from the table from research article and the results are not accurate. I have similar observations with other tables also. Often some values are missing and often some ...

Air France–KLM Group has saved more than 200,000 hours of manual work since rolling out its RPA (Robotic Process Automation) initiative, but that number only tells part of the story. From food waste ...

Cardiff Oncology has reported updated results from its phase 2 colorectal cancer trial, laying out data it believes can support talks with the FDA about a registrational program. Investors, though, ...